載入...

Treatment modalities and drug survival in a systemic sclerosis real-life patient cohort

BACKGROUND: European data indicate that systemic sclerosis (SSc)-related death rates are increasing, thus raising concerns about SSc’s optimal management. Herein, we describe current treatment modalities and drug survival in a real-life SSc cohort. METHODS: Details on immunosuppressive/antiprolifera...

全面介紹

Na minha lista:
書目詳細資料
發表在:Arthritis Res Ther
Main Authors: Panopoulos, S., Chatzidionysiou, Κ., Tektonidou, M. G., Bournia, V. K., Drosos, A. A., Liossis, Stamatis-Nick C., Dimitroulas, T., Sakkas, L., Boumpas, D., Voulgari, P. V., Daoussis, D., Thomas, K., Georgiopoulos, G., Vosvotekas, G., Garyfallos, Α., Sidiropoulos, P., Bertsias, G., Vassilopoulos, D., Sfikakis, P. P.
格式: Artigo
語言:Inglês
出版: BioMed Central 2020
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC7092571/
https://ncbi.nlm.nih.gov/pubmed/32293545
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-020-2140-3
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!